Indian Journal of Urology: Article Access Statistics

Users online:1071

Article Access Statistics

Year : 2022 | Volume: 38 | Issue Number: 4 | Page: 319-320

UROSCAN

PROpel trial: Are PARP inhibitors ready to become the first-line treatment for mCRPC?
Gaur Abhay Singh


Number of times this article was viewed	826
Number of times this article has been printed from the site	18
Number of times this article was emailed to others	0
Remarks given by readers [ Read ]	0

The Journal

Addresses

e-Alerts

Back To Article